Small Molecule Discoidin Domain Receptor Kinase Inhibitors and Potential Medical Applications-Reference-Cited by-同舟云学术

Small Molecule Discoidin Domain Receptor Kinase Inhibitors and Potential Medical Applications

Published:2015-01-21 Issue:8 Volume:58 Page:3287-3301
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Li Yupeng¹²,Lu Xiaoyun¹,Ren Xiaomei¹,Ding Ke¹

Affiliation:

1. State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, No. 190 Kaiyuan Avenue, Guangzhou 510530, China

2. University of Chinese Academy of Sciences, No. 19 Yuquan Road, Beijing 100049, China

Funder

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Guangdong Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm5012319

Reference154 articles.

1. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues.

2. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From pixels to druggable leads: A CADD strategy for the design and synthesis of potent DDR1 inhibitors;Computer Methods and Programs in Biomedicine;2024-09

2. Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR);ChemistrySelect;2024-08-06

3. A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye;British Journal of Pharmacology;2024-07-08

4. Discovery of LLC355 as an Autophagy-Tethering Compound for the Degradation of Discoidin Domain Receptor 1;Journal of Medicinal Chemistry;2024-05-10

5. DDR1-targeted therapies: current limitations and future potential;Drug Discovery Today;2024-05